Market Tracker

11/21 6:05pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

16.23
Data as of Nov 21
 +0.54 / +3.44%
Today’s Change
5.40
Today|||52-Week Range
25.60
+119.62%
Year-to-Date

Today’s Trading

Previous close15.69
Today’s open15.94
Day’s range15.50 - 16.27
Volume683,101
Average volume (3 months)1,447,666
Market cap$762.6M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-101.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book7.02

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.02+0.09%
MGNXMacroGenics Inc+1.11+4.25%
EPZMEpizyme Inc-1.07-4.54%
OREXOrexigen Therapeutic...+0.12+2.08%
Data as of 3:59pm ET, 11/21/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts